id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-P-0044-0005,FDA,FDA-1997-P-0044,"Citizen Petition Approval Response Letter from FDA CDER to McDermott, Will & Emery",Other,Approval,2017-08-30T04:00:00Z,2017,8,2017-08-30T04:00:00Z,,2017-08-30T13:47:16Z,,0,0,09000064805cfc74
FDA-1997-P-0044-0003,FDA,FDA-1997-P-0044,"Attachment 1 Approved Drug Products With Therapeutic Equivalence Evaluations 13th Edition re Citizen Petition from McDermott, Will & Emery",Supporting & Related Material,Background Material,2017-08-30T04:00:00Z,2017,8,,,2017-08-30T13:44:20Z,,0,0,0900006482a202a5
FDA-1997-P-0044-0004,FDA,FDA-1997-P-0044,"Attachment 2 Approved Drug Products With Therapeutic Equivalence Evaluations 14th Edition re Citizen Petition from McDermott, Will & Emery",Supporting & Related Material,Background Material,2017-08-30T04:00:00Z,2017,8,,,2017-08-30T13:45:29Z,,0,0,0900006482a202a6
FDA-1997-P-0044-0002,FDA,FDA-1997-P-0044,"Citizen Petition from McDermott, Will & Emery",Other,Citizen Petition,2017-08-30T04:00:00Z,2017,8,1997-06-26T04:00:00Z,,2017-08-30T13:41:56Z,,0,0,09000064805cfc73
FDA-1997-P-0044-0001,FDA,FDA-1997-P-0044,"Acknowledgment Letter from FDA DDM to McDermont, Will and Emery",Other,Acknowledgement Letter/Receipt,1997-06-26T04:00:00Z,1997,6,,,2017-08-17T17:11:22Z,,0,0,09000064805cfc71